Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 10/20 | 0.49 |
| ▸ | EPAS1 | Q99814 | 4/20 | 0.49 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | MDH1 | P40925 | 2/20 | 0.43 |
| ▸ | MDH2 | P40926 | 2/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9126429 | 0.83 | HIF1A (0.60) | HIF1AEPAS1SERPINE1KMT2AMEN1 | |
| SCHEMBL28094060 | 0.82 | SERPINE1 (0.50) | HIF1AEPAS1SERPINE1KMT2AMEN1 | |
| SCHEMBL7501343 | 0.81 | HIF1A (0.48) | HIF1AEPAS1SERPINE1KMT2AMEN1 | |
| SCHEMBL9124033 | 0.79 | SERPINE1 (0.55) | HIF1AEPAS1SERPINE1KMT2AMEN1 | |
| SCHEMBL422675 | 0.79 | SERPINE1 (0.58) | HIF1AEPAS1SERPINE1KMT2AMEN1 | |
| SCHEMBL28197968 | 0.78 | HIF1A (0.55) | HIF1AEPAS1SERPINE1KMT2AMEN1 | |
| SCHEMBL27847928 | 0.73 | MEN1 (0.59) | HIF1AEPAS1SERPINE1KMT2AMEN1 | |
| SCHEMBL417009 | 0.72 | RAB9A (0.53) | HIF1AEPAS1KMT2AMEN1RAB9A | |
| SCHEMBL9124063 | 0.72 | HIF1A (0.51) | HIF1AEPAS1SERPINE1KMT2AMEN1 | |
| SCHEMBL28906363 | 0.72 | RARA (0.56) | KMT2AMEN1CNR2EPHX2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8450377-B2 | 1-adamantyl chalcones for the treatment of proliferative disorders | ANDERSON GLORIA L (US) | 2013-05-28 | — | — | US | disclosed |
| US-20110319483-A1 | 1-ADAMANTYL CHALCONES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | ANDERSON GLORIA L (US) | 2011-12-29 | — | — | US | disclosed |
| US-8013020-B2 | 1-adamantyl chalcones for the treatment of proliferative disorders | Anderson et al., Gloria L. (US) | 2011-09-06 | — | — | US | disclosed |
| US-20090281196-A1 | 1-ADAMANTYL CHALCONES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | ANDERSON GLORIA L | 2009-11-12 | — | — | US | disclosed |
| US-7563789-B2 | 1-Adamantyl chalcones for the treatment of proliferative disorders | ANDERSON GLORIA LONG | 2009-07-21 | — | — | US | disclosed |
| US-20060189580-A1 | 1-Adamantyl chalcones for the treatment of proliferative disorders | ANDERSON GLORIA L | 2006-08-24 | — | — | US | disclosed |
| US-20050065152-A1 | 1-Adamantyl chalcones for the treatment of proliferative disorders | ANDERSON GLORIA L (US) | 2005-03-24 | — | — | US | disclosed |
| US-6864264-B1 | 1-adamantyl chalcones for the treatment of proliferative disorders | ANDERSON GLORIA L (US) | 2005-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065152-A1 | 1-Adamantyl chalcones for the treatment of proliferative disorders | BRCA1, CYP19A1, HSD17B11 | HIF1A 1103/4885EPAS1 3057/4885SERPINE1 436/4885 |
| US-20060189580-A1 | 1-Adamantyl chalcones for the treatment of proliferative disorders | BRCA1, CYP19A1, HSD17B11 | HIF1A 1103/4885EPAS1 3057/4885SERPINE1 436/4885 |
| US-20090281196-A1 | 1-ADAMANTYL CHALCONES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | BRCA1, CYP19A1, HSD17B11 | HIF1A 1103/4885EPAS1 3057/4885SERPINE1 436/4885 |
| US-20110319483-A1 | 1-ADAMANTYL CHALCONES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | BRCA1, CYP19A1, HSD17B11 | HIF1A 1103/4885EPAS1 3057/4885SERPINE1 436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.